Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.77 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL722087 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL16289663 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL4257733 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL4335281 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL2411393 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL3092973 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL466711 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL18140350 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL18140847 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL722452 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114846125-B | Lubricating oil composition | 出光兴产株式会社 | 2024-01-16 | — | — | CN | claimed |
| US-9522114-B1 | Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin | UNIVERSITY OF SOUTH FLORIDA (US) | 2016-12-20 | — | — | US | claimed |
| US-20100068264-A1 | NIOSOME-HYDROGEL DRUG DELIVERY SYSTEM | UNIVERSITY OF SOUTH FLORIDA (US) | 2010-03-18 | — | — | US | claimed |
| EP-4376864-A1 | THERAPEUTIC FORMULATIONS FROM PELARGONIUM SP. AND METHOD OF USE IN RESPIRATORY VIRAL INFECTIONS | Subhadra, Bobban (US) | 2024-06-05 | — | — | EP | disclosed |
| CN-114846125-B | Lubricating oil composition | 出光兴产株式会社 | 2024-01-16 | — | — | CN | disclosed |
| WO-2023009976-A1 | THERAPEUTIC FORMULATIONS FROM PELARGONIUM SP. AND METHOD OF USE IN RESPIRATORY VIRAL INFECTIONS | SUBHADRA BOBBAN (US) | 2023-02-02 | — | — | WO | disclosed |
| US-9522114-B1 | Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin | UNIVERSITY OF SOUTH FLORIDA (US) | 2016-12-20 | — | — | US | disclosed |
| US-8563493-B2 | Oil composition for cosmetics | DAICEL CORPORATION (JP) | 2013-10-22 | — | — | US | disclosed |
| EP-2484338-A1 | OIL COMPOSITION FOR COSMETICS | Daicel Chemical Industries, Ltd. (JP) | 2012-08-08 | — | — | EP | disclosed |
| US-20120184476-A1 | OIL COMPOSITION FOR COSMETICS | DAICEL CORPORATION (JP) | 2012-07-19 | — | — | US | disclosed |
| US-20100260830-A1 | Liposomal Formulations of Tocopheryl Amides | SALVATORE BRIAN A | 2010-10-14 | — | — | US | disclosed |
| WO-2010118200-A2 | LIPOSOMAL FORMULATIONS OF TOCOPHERYL AMIDES | SALVATORE BRIAN (US) | 2010-10-14 | — | — | WO | disclosed |
| US-20100068264-A1 | NIOSOME-HYDROGEL DRUG DELIVERY SYSTEM | UNIVERSITY OF SOUTH FLORIDA (US) | 2010-03-18 | — | — | US | disclosed |
| WO-2004014152-A1 | MULTI-PHASE DELIVERY SYSTEM COMPRISING A SEMI-SOLID MATRIX PHASE | VITALSTATE CANADA LTD. (CA) | 2004-02-19 | — | — | WO | disclosed |
| WO-2004009053-A2 | ORAL DELIVERY SYSTEM CONTAINING A GEL MATRIX AND LIPOSOMES | VITALSTATE CANADA LTD. (CA) | 2004-01-29 | — | — | WO | disclosed |
| EP-1192920-A1 | Comfortable foam-based ear plugs | The Procter & Gamble Company (US) | 2002-04-03 | — | — | EP | disclosed |
| US-5358716-A | Oil in water emulsion; nonionic vesicles prepared from nonionic amphiphilic liquid; oxidation resistance | L'OREAL (FR) | 1994-10-25 | — | — | US | disclosed |